Abstract
The management of pregnant patients with coagulopathies and heparin induced thrombocytopenia is difficult and poorly defined. We report the case of a patient who was treated with a low molecular weight heparinoid. The treatment was complicated by the delayed occurrence of thrombocytopenia and a thrombotic event. This is the first report of thrombocytopenia caused by heparinoid. It is possible that this complication could have been avoided by a shorter duration of treatment with heparinoid and the use of Vitamin K antagonists during the second trimester of pregnancy.
MeSH terms
-
Adult
-
Blood Coagulation Disorders / complications
-
Blood Coagulation Disorders / drug therapy*
-
Blood Coagulation Disorders / immunology
-
Blood Coagulation Factors / analysis
-
Blood Coagulation Factors / immunology
-
Chondroitin Sulfates*
-
Dermatan Sulfate*
-
Female
-
Glycosaminoglycans / therapeutic use*
-
Heparin / adverse effects*
-
Heparinoids / therapeutic use*
-
Heparitin Sulfate*
-
Humans
-
Lupus Coagulation Inhibitor
-
Pregnancy
-
Pregnancy Complications, Hematologic / chemically induced
-
Pregnancy Complications, Hematologic / drug therapy*
-
Pregnancy Complications, Hematologic / immunology
-
Thrombocytopenia / chemically induced
-
Thrombocytopenia / complications
-
Thrombocytopenia / drug therapy*
Substances
-
Blood Coagulation Factors
-
Glycosaminoglycans
-
Heparinoids
-
Lupus Coagulation Inhibitor
-
Dermatan Sulfate
-
Heparin
-
Chondroitin Sulfates
-
Heparitin Sulfate
-
danaparoid